Protagonist Therapeutics, Inc Property, Plant and Equipment, Gross
Protagonist Therapeutics, Inc (PTGX) had Property, Plant and Equipment, Gross of $12.57 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentGross · last filed 2026-08-05
- 2026-06-30: Property, Plant and Equipment, Gross $12.57M.
- 2026-03-31: Property, Plant and Equipment, Gross $12.50M.
- 2025-12-31: Property, Plant and Equipment, Gross $12.18M.
- 2025-09-30: Property, Plant and Equipment, Gross $12.04M.
| Period end | Property, Plant and Equipment, Gross |
|---|---|
| 2026-06-30 | $12.57M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $12.50M 10-Q · filed 2026-05-05 |
| 2025-12-31 | $12.18M 10-Q · filed 2026-08-05 |
| 2025-09-30 | $12.04M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $11.69M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $10.80M 10-Q · filed 2025-05-06 |
| 2024-12-31 | $10.22M 10-K · filed 2026-02-25 |
| 2024-09-30 | $9.40M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $8.48M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $7.58M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $7.43M 10-K · filed 2025-02-21 |
| 2023-09-30 | $7.37M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $6.98M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $6.83M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $6.82M 10-K · filed 2024-02-27 |
| 2022-09-30 | $6.75M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $6.70M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $6.59M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $6.06M 10-K · filed 2023-03-15 |
| 2020-12-31 | $4.93M 10-K · filed 2022-02-28 |
| 2019-12-31 | $4.32M 10-K · filed 2021-03-10 |
| 2019-09-30 | $4.29M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $4.08M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $3.75M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $2.94M 10-K · filed 2020-03-10 |
| 2017-12-31 | $2.47M 10-K · filed 2019-03-12 |
| 2016-12-31 | $1.88M 10-K · filed 2018-03-07 |
| 2015-12-31 | $1.64M 10-K · filed 2017-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |